This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Functional Cerebral SPECT and PET Imaging
edited by Ronald L. Van Heertum and Ronald S. Tikofsky,
336 pp., Philadelphia, Lippincott Williams & Wilkins, 2000, $159
This book is a timely contribution to the burgeoning field of functional brain imaging. The first part of the book addresses the basic physics and principles of SPECT and PET instrumentation followed by the anatomic landscape of the brain and the current understanding of the function of various regions within the brain. In part II of the book, each chapter is devoted to a disease process where SPECT and PET have made substantial contributions. This book covers imaging, and it delivers on these expectations by devoting the majority of the pages to images rather than text. This primary focus on images to illustrate different patterns in various disease states adds strength to the book, having been revised and expanded to include PET imaging. A large section is devoted to the measurement of blood flow in cerebrovascular diseases, dementia, seizures, and head trauma. This is followed by a chapter on psychiatric disorders, brain tumors, and miscellaneous topics such as Lyme disease, encephalopathy, and tinnitus. A final smattering of receptor binding imaging and activation protocols completes this volume.
The first two chapters introduce the basic imaging principles in a straightforward and intelligible style. Radiation risk is explained well and removes some of the common myths. Various corrections important for quantitative recovery of data are included in the second chapter, and they are a welcome addition to the principles of PET imaging. The statement that “no PET tracer for the imaging of neuronal function has received FDA approval” may have been included when the book went to press. Since March 2000, 18F-fluorodeoxyglucose (18FDG) has been approved for epilepsy and is commercially available in most major cities. …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg